Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India

Safdarjang Hospital, New Dilli, NCT, India
Sex Transm Dis (Impact Factor: 2.75). 07/2003; 30(6):523-5. DOI: 10.1097/00007435-200306000-00010
Source: PubMed

ABSTRACT Resistance of ciprofloxacin has been reported in several regions of the world, including India. In India, ciprofloxacin is still being used as single-dose treatment for gonorrhea.
The aim of the study was to determine the antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients with acute gonococcal urethritis in New Delhi.
By means of disc diffusion, we determined the susceptibility profiles of N gonorrhoeae isolates, determined the MICs of ciprofloxacin, penicillin, and ceftriaxone, and compared our data with previous findings.
On the basis of MIC values, 35.3% and 52.9% of strains were found to be resistant and less sensitive, respectively, to penicillin; 67.3% and 28.2% strains were observed to be resistant and less sensitive, respectively, to ciprofloxacin. Only one isolate (5.9%) was found to be less sensitive to ceftriaxone.
The significant increase in ciprofloxacin resistance in the current study indicates that resistance has developed under selective antibiotic pressure.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: it's essential to monitor the susceptibility of N. gonorrhoeae to antibiotics as a means of assuring the efficiency of the therapeutic protocols. This study was designed to test the behavior of strains of N. gonorrhoeae betalactamase producer against threes of the most frequently pre- scripts antibiotic for the management of gonoccocal urethral and cervical discharge in our region. Objective: to determine, using ephysolometric method, the in vitro susceptibility of N. gonorrhoeae betalactamase producers strains against azithromycin, ceftriaxone and ciprofloxacin. Method: the ephisolometric test (e-test) was used to determine the susceptibility of 41 strains of N. gonorrhoeae betalactamase producer against azithromycin, ceftriaxone and ciprofloxacin in samples of urethral and cervical discharge colleted from patients seen at the Sexual Transmitted Disease Center of Fundação Alfredo da Matta (FUAM) from July to December, 2002. Results: the results showed that 21,9% (9/41) of the strains were resistant to azithromycin and 29,6% (12/41) showed reduced sensibility. Nine point seven percent (9,7% - 4/41) of the isolates showed reduced sensibility against ciprofloxacin, whereas towards ceftriaxone the sensibility was 95,1% (39/41). The MIC four two of the strains tested against ceftriaxone were above 0,25µg/ml which is the highest value for sensibility to this antibiotic. Conclusion: this study is the first report of N. gonorrhoeae resistant to azithromycin among the patients seen at FUAM. Also, it's important to underline the demonstration of reduced sensibility to ciprofloxacin and MIC values above the standard for sensibility to ceftriaxone. These results raise the possibility of therapeutic failure in the near future when these antibi- otics are used in the treatment. It is important to maintain programs of periodic evaluation of the drugs used in the syndromic treatment of urethral and cervical discharge.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The recent re-emergence of gonorrhoea in developed countries has been accompanied by the rise and spread of gonococcal resistance to the fluoroquinolones. In the 1980s fluoroquinolones were considered an important addition to the arsenal of agents used to treat gonorrhoea. They proved to be excellent drugs for this indication, including infections caused by penicillinase-producing and tetracycline-resistant strains of Neisseria gonorrhoeae. However, as gonococci have a well-recognised potential to develop resistance to antibiotics, the first reports of reduced susceptibility to fluoroquinolones appeared a few years after their introduction. Gonococcal resistance to fluoroquinolones is now well-established in the Far East, from where it has spread to Australia, Hawaii, California and Europe. In Africa and Latin America, gonococci continue to be susceptible to fluoroquinolones.
    Expert Opinion on Pharmacotherapy 05/2004; 5(4):829-54. DOI:10.1517/14656566.5.4.829 · 3.09 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in quinolone resistance-determining regions (QRDRs) have been associated with quinolone-resistant Neisseria gonorrhoeae (QRNG). Since diagnostic nucleic acid amplification tests for gonococci are now in frequent use, molecular detection of QRNG could facilitate surveillance in the absence of culture. Here we describe a real-time molecular assay for detecting QRDR mutations in gonococci.
    Journal of Clinical Microbiology 08/2004; 42(7):3281-3. DOI:10.1128/JCM.42.7.3281-3283.2004 · 4.23 Impact Factor